What if menopause were optional?

is a senior correspondent for Vox, where she covers American family life, work, and education. Previously, she was an editor and writer at the New York Times. She is also the author of three novels, including the New York Times bestseller Outlawed.
Will my generation be the last to go through menopause?
Just a few years ago, that would've seemed like a bizarre question — I've always assumed that I and every other human being with ovaries would eventually experience what my grandmother called 'the change of life.' But now, researchers are calling into question what once seemed like basic facts of human existence. 'What if menopause happened later?' they are asking. 'What if it never happened at all?'
In recent years, patients have gained access to a wider variety of medications to treat menopausal symptoms like hot flashes and vaginal dryness. But newer treatments, one already in clinical trials, go deeper: The goal is not just to treat the symptoms, but to actually slow down ovarian aging so that the hormonal changes associated with midlife happen later — or maybe even never. 'For the first time in medical history, we have the ability to potentially delay or eliminate menopause,' Kutluk Oktay, an ovarian biologist at Yale University, said in a release last year.
I cover reproductive health, and my inbox has been filling up for months with news of research like this. As an elder millennial barreling toward the uncertainty of perimenopause (which some research suggests can start as early as one's 30s), I've received these updates with interest, sure, but also with a fair amount of trepidation.
On the one hand, the loss of estrogen that comes with menopause is associated with a host of illnesses and conditions, from cardiovascular disease to osteoporosis. Delaying the menopausal transition even five years 'would result in an enormous improvement in terms of women's health and decreased mortality,' Zev Williams, the chief of reproductive endocrinology and infertility at Columbia University Irving Medical Center, told me. 'It's a really exciting opportunity.'
On the other hand, the idea of getting rid of menopause can feel like yet another way of insisting that women remain young and fertile forever. At a time when JD Vance is talking dismissively about the 'purpose of the postmenopausal female,' I'm unsettled by the prospect of treating women's aging out of their childbearing years, in particular, as something that must be cured.
If the idea of stopping menopause is a fraught one, though, it's also an opportunity to think about what we want from our later lives, and to consider what it would look like to balance the real medical concerns of midlife and beyond with the fact that women are flesh-and-blood human beings who, like everyone else, get old. As Ashton Applewhite, author of the book This Chair Rocks: A Manifesto Against Ageism, put it to me, 'you can't stop aging, or you're dead.'
To understand menopause, it helps to understand a little bit about ovaries, the human reproductive organs that store and release eggs. Starting in puberty, these glands ramp up their production of estrogen, a hormone that leads to breast development and a host of other changes to the body. Throughout the reproductive years, the ovaries make estrogen and other hormones according to a monthly cycle to help prepare the body for potential pregnancy.
Starting around a person's late 30s, however, estrogen production starts to drop off. By the mid-40s, people typically enter perimenopause, which means 'around menopause.' This period is characterized by unpredictable ups and downs in estrogen, though on a general downward trend (Mary Jane Minkin, an OB-GYN who teaches at the Yale School of Medicine, likens the pattern to the stock market during the Great Recession). That hormonal decline can lead to symptoms like irregular periods, hot flashes, and night sweats.
A lot of the symptoms most commonly associated with menopause actually start in perimenopause, and they can range from annoying to devastating. Perimenopause has been getting a lot of media attention lately, along with more focus from brands who may want to sell you stuff to help you manage it. Problems like hot flashes and brain fog can cause women to miss work, resulting in $1.8 billion in lost work productivity in the US per year, according to one study. The loss of estrogen can cause vaginal dryness, which can cause discomfort during sex and, in some cases, constant pain.
At some point, the ovaries stop producing eggs, and menstruation stops entirely. This is menopause, and it's diagnosed when someone has gone without a period for a full year. It happens at an average age of 51, though Black and Latina women reach menopause earlier than white and some Asian American women. Though some symptoms, like dryness, persist after menopause, others, like hot flashes, often resolve, Minkin told me.
Hormonal changes in the body around menopause are also linked with increased risk of cardiovascular disease, Stephanie Faubion, director of the Mayo Clinic's Center for Women's Health and medical director of the Menopause Society, told me. Blood pressure and cholesterol tend to rise during this time, as does insulin resistance, a condition that can lead to diabetes. Bone density also falls during and after the menopause transition, increasing the risk of osteoporosis.
Some experts believe that menopause is part of the reason women spend more time than men living with chronic diseases. 'Women live longer than men,' gerontology professor Bérénice Benayoun told Vox last year, 'but they usually do so in a much more frail state.'
Given all this, it's reasonable that more experts are looking at menopause and wondering, what if we could just…not?
Hormone therapy — typically estrogen taken on its own or with progesterone, sometimes in the form of birth control pills — already exists to treat the symptoms of menopause. The treatment was stigmatized for decades after a 2002 study linked it to breast cancer and other ailments, but doctors now say the benefits often outweigh the risks. Taking estrogen can dramatically reduce hot flashes, and even reduce cardiovascular risk while patients are on the medication.
When you look at illnesses and conditions like dementia, heart disease, and stroke, 'there's a much, much lower rate in women compared to men, until ovarian function stops. Then they start to catch up,' Williams said. 'If we have a way of extending the ovarian lifespan in a way that's safe, then you're allowing the ovary to provide all these incredible health benefits' for a longer period of time.
Estrogen therapy can replace some of the estrogen a person's ovaries are no longer producing, but it doesn't actually stop those organs' decline. To do that, some researchers are looking at more involved procedures.
In one recent study, Oktay, the Yale biologist, and his team used a mathematical model to predict how a technique called ovarian tissue cryopreservation might work in healthy patients. The process, typically used in cancer patients undergoing treatment that could harm their fertility, involves removing a section of ovary, freezing it, and reimplanting it at a later date. This technique, if used in healthy patients under 40, 'would result in a significant delay in menopause,' according to the study.
Oktay and his team have begun preserving ovarian tissue from healthy patients, with the goal of reintroducing it when the patients are close to menopause. Since the women are still young, the team will have to wait years for real-world results, Oktay told me. But the technique does work to restore ovarian function in cancer survivors, he said.
About 10 percent of women enter menopause at age 55 or older, Oktay told me, and they tend to have longer life expectancy and less risk of osteoporosis and diabetes than people who go through the transition earlier. 'We're saying, why not make everybody that lucky?'
Williams, the Columbia endocrinologist, and his team are working on a different, less invasive option. They're currently in the midst of their first human trial of rapamycin, an oral medication typically used as an immunosuppressant in higher doses. Rapamycin has been found to extend lifespan in some animal studies, suggesting to some that it might help humans live longer. Williams and his team have also found that the drug can extend ovarian function and fertility in mice.
The Columbia researchers are now monitoring 50 women between the ages of 35 and 45 who have taken either rapamycin or a placebo, asking them questions about their mood, memory, and sleep quality, as well as checking their ovarian function through blood work and ultrasounds. They don't have results yet, but they've seen no serious side effects so far.
The goal isn't just to extend fertility, though 'as a fertility specialist, that's obviously something that I think about all the time,' Williams said. It's also about extending the benefits that ovaries provide to women's health, potentially reducing their lifetime risk of chronic illness.
Research like Williams's has generated significant excitement, as the idea of pushing back menopause starts to move into the mainstream. Toward the end of the Biden administration, Jill Biden launched a women's health initiative dedicated to studying the idea.
The ovaries are 'the only organ in humans that we just accept will fail one day,' Renee Wegrzyn, director of the agency in charge of the first lady's initiative, told the New York Times last year. 'It's actually kind of wild that we all just accept that.'
Some are skeptical, though, that delaying or eliminating menopause would be an entirely good idea.
For one thing, the link between menopause and illness isn't completely clear-cut. People who go through menopause later tend to have better health outcomes, 'but is it chicken or egg?' Faubion asked. 'Do their ovaries last longer because they're otherwise in better general health than the other people that go through menopause early?'
Prolonging ovarian function — and thus increasing people's lifetime exposure to estrogen — could also come with risks of its own, like increases in breast cancer or blood clots, which have been linked to the hormone, Faubion said (going through menopause after age 55 is associated with an increased risk of breast cancer). For some, the tradeoffs might be worth it, but it's not necessarily true that later menopause would mean better health across the board.
With more invasive treatments, there are also other questions to consider. 'What are the ethics of taking out a healthy organ from a healthy person' — a surgical procedure that could fail — 'all in the name of 'delaying menopause?'' Faubion asked.
Oktay, the biologist studying ovarian tissue cryopreservation, told me the procedure is a minimally invasive laparoscopic surgery, and can be performed at the same time as another abdominal surgery like a C-section. Many participants in his study have a family history of severe menopause complications or conditions that can worsen with menopause, he said, giving them a reason to want to delay the transition.
For Minkin, the Yale gynecologist, the experimental treatments are intriguing if they can extend fertility. But for dealing with the physical challenges of menopause, she's not sure they're necessary: 'There are plenty of easy ways to give people hormones.'
Some people, including survivors of certain cancers, aren't able to take hormones, and new treatments could be helpful for them. Meanwhile, some experts see delaying menopause as most beneficial for people who experience the transition early. About one percent of women go through menopause before age 40, and five percent before age 45. Cancer treatments or autoimmune conditions can cause early menopause, but sometimes, the cause is unknown. Since early menopause is associated with elevated health risks, a new way to treat it 'would probably result in a net benefit for population health,' Nanette Santoro, a professor of obstetrics and gynecology at the University of Colorado School of Medicine, told Time.
Going through menopause early can be deeply upsetting to people, especially (though not exclusively) if they're hoping to have children. But when it happens at the average time, this stage of life can come with social and emotional benefits, despite the physical challenges.
'It's liberating,' Applewhite told me. 'No more mood swings, no more worries about getting pregnant.'
'I don't know any woman, including yourself, who wants to be bleeding every single month,' Denise Pines, creator of the menopause summit WisePause, told me.
Indeed, research has found that women often become happier as they age, especially after midlife — potentially because they're less consumed with caring for children and other family members. Some anthropologists believe that female humans, unlike other animals, live beyond their reproductive years to help care for grandchildren (it's called the 'grandmother hypothesis'). But Minkin offered a more expansive view of this theory: In early human settlements, pregnant people couldn't do heavy labor like moving rocks around. The grandmother was 'somebody who moves the rocks,' she said. She also described postmenopausal women as 'shooting saber-toothed tigers.'
Even the troublesome symptoms of menopause, such as hot flashes and night sweats, can be a useful 'disruptor' in people's lives, Pines said. 'Where women have been so giving and outwardly focused, suddenly you have to focus on yourself.'
'That gives you a chance to reset everything else around you,' from relationships to career, Pines said. 'It's such a great time to really reimagine who we are.'
Applewhite welcomes the recent surge in awareness around menopause, and says hormone therapy to treat its symptoms can be helpful — 'I'm not saying, keep your body pure and avoid the temptations of Western medicine.' But when it comes to putting off menopause or eliminating it entirely, she said it's concerning 'when inevitable transitions of aging are pathologized.' That's especially true for women's aging, which is doubly stigmatized in American culture. 'Under patriarchy, a woman's value is linked to her reproductive value,' Applewhite said. It's why there's so little research into the health of older women: 'because we are no longer reproductively useful.'
As appealing as the idea of extending a person's healthy lifespan is, I can't quite get past the ovary of it all. I, too, have heard from post-menopausal people about the liberation they feel when they exit their reproductive years. I, too, have at times been frustrated by doctors' focus on my reproductive capacity over other aspects of my health. I want to be healthy as I get older, but I also want to accept my aging (and for the people around me to accept it), rather than feeling constant pressure to stave it off.
Applewhite wants women of all ages to see 'later life as a time of enormous power and liberation and possibility,' and I'd like to see it that way too, not as something to be avoided at all costs.
When I shared some of these concerns with Williams, he asked me if I'd feel the same trepidation around treatments that focused on other areas of the body. 'You want to extend normal heart function, liver function,' he said. But 'for some reason, if you say, we want to slow ovarian aging, that touches on a very different note.'
It's a fair point, especially since a lot of the health outcomes he and others are trying to promote aren't about fertility or attractiveness or any of the attributes our culture demands that women maintain in our quest to remain forever young — they're about things like cardiovascular and mental health. I want those!
Williams argued that understanding ovarian aging might actually remove some of the negative messages around menopause and getting older more generally. He also studies recurrent miscarriage, which 'has always had a tremendous amount of stigma associated with it.' What's helped reduce that stigma has been 'when it goes away from this realm of myth and taboo and folklore, and we start to understand the process,' he says.
It's worth noting that research into menopause, like so much work on reproductive health and indeed health in general, is imperiled under the Trump administration. When I tried to visit the website for Jill Biden's menopause initiative, I found that it was gone. Renee Wegrzyn, the head of the initiative, was fired in February. In a time when a lot of medical research is simply disappearing, it's hard to look askance at treatments that could improve people's lives.
After talking to Williams and other experts, I'm not against the idea of a medication that could help people live longer without heart attacks or cognitive decline. But as I get older, I'm also keenly aware that what happens outside our bodies can affect our health as much as what happens inside them.
When I asked Pines what she'd like to see for people in perimenopause and menopause right now, she said she wants a future when people in this stage of life 'are not dismissed,' when 'we can talk about menopause the same way we talk about puberty.' She'd also like to see workplaces support women experiencing perimenopause symptoms, including by offering insurance plans that cover the treatment of them. And she wants OB-GYNs, internists, and other doctors to be specifically trained in perimenopause and menopause, something that's often lacking.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Journals

3 hours ago

• Business Journals

3 simple steps for employers to lower health care costs and ensure better employee care

It's no secret that the current health care system is unsustainable. Nearly half of Americans receive health care coverage through their employer and over the past two decades, employer-sponsored health care costs have risen by over 200%. Many businesses can no longer front the costs — and the burden is being shifted onto employees. The result? Health care has become unaffordable for many working Americans — for some employees cost shifting has made engaging care unaffordable and 40% of American adults are struggling with medical debt — a shockingly high number. Despite this astronomical rise in cost, most brokers and benefits consultants haven't changed the solutions they present to clients in decades. In our experience, only about 5-10% of brokers are offering their clients innovative alternatives and even fewer have fully embraced a different approach, leading to poor implementation and support when they do try something new. The reality is that health care operates as an inefficient market. Unlike most industries, higher costs do not necessarily equate to higher quality care — in fact, it can often be the opposite. We believe that by being proactive, transparent and strategic, employers can reverse this trend by reducing costs while ensuring their employees receive top-quality care. However, achieving transformational results demands a completely different approach. The four of us have spent years in this industry and have tailored a unique approach that enables us to achieve superior results. We've seen what works and what doesn't and the ineffective options continually peddled to employers. That's why we've joined forces to help employers to take control of their health care spend and save real money. Our approach We don't believe in a one-size-fits all health plans and we partner with HR leaders to bring their health care strategy to life while directly administering the change. This includes educating employees on what they need to know to make the most of their benefits. When you show people exactly how they can receive better care at a lower price, everyone wins. Our model is built on three pillars: education, pharmacy platform and Medicare Plus. Education: We empower members to navigate the health care system effectively and steer them towards high quality and cost-effective options. Navigating the health care system is hard and we take a hands-on approach, which helps members understand their choices and make informed decisions. This extra effort improves health outcomes while ensuring the best experience possible. According to publicly available data compiled by Image360, CT scans in Tampa, Florida, are typically billed between $4,500 and $9,700. Even after PPO discounts, health plan members and businesses still pay $2,200 to $4,800. The problem is, there's little transparency in pricing and high cost doesn't guarantee high quality. Imagine360 changes that. With Imagine360, the average cost for the same CT scan at the same facility drops to under $200. This translates to significant savings for the employee and the business. Pharmacy platform: Pharmacy spend is the fastest-growing expense when it comes to a health plan. Traditional solutions often lack transparency and instead function as profit centers. We craft innovative solutions to manage pharmacy costs, ensuring that members have access to affordable medications without compromising on quality. Medicare Plus: We provide a thoughtful alternative to conventional PPOs. This model offers robust coverage at significantly lower costs by anchoring reimbursements to fair, Medicare-based rates. The above approach collectively has proven to cut costs by nearly 25% on average. Through this approach, we've reduced the cost of health care so drastically that some clients now offer no-cost health care to all of their employees. At a time when most companies are forcing employees to pay upwards of thousands of dollars per month on health insurance premiums, our clients pick up the full cost of premiums for their employees. This difference is life-changing for many families. By adopting a three-pillar approach to health care benefits, these businesses have become highly sought-after employers in their communities. And it's not just beneficial for employees — it's advantageous for the health plan as well. When health care premiums are overpriced, only the highest utilizers enroll, which makes sense; you would only pay thousands of dollars a month in premiums if you anticipated high health care expenses. However, when coverage is affordable and well-structured, everyone participates, creating a healthier, more predictable and sustainable plan. If this sounds too good to be true, you're not alone. One employer came to us frustrated and skeptical. Every broker had pitched the same traditional solutions, none of which solved their problem. Their chief financial officer knew that if they could not control hospital claims costs, the business would be in trouble. We introduced Medicare Plus pricing as a strategic solution. We helped manage the learning curve for the first few months — but once leadership committed to the solution, the plan started working. Three years in, premiums, deductibles and copays have all dropped. Employees are getting better coverage, and the company has even added new benefits — while most of their peers are cutting back. Using an independent TPA Working with an independent third-party administrator (TPA) opens the door to a different and better playbook. Yes, it takes more work upfront — more education, communication, teamwork — but the payoff is worth it: a more flexible employee benefits solution that can lead to better care, lower costs, and long-term consistency. No more carrier swaps or yearly overhauls. We currently support 25 clients on this platform. With dedicated service teams, personalized enrollment education and long-term strategies, we help employers innovate — without impacting employee satisfaction. The result is a smoother, more positive experience. The road ahead We're all fighting the same fight: pushing back against a system that hides cost, limits choices, wastes money and is driving people to choose little or no coverage due to cost. But it doesn't have to be this way. With a three-pronged approach including employee education, pharmacy and Medicare Plus pricing, we're helping employers take back control of their health care costs. By putting people first and staying committed to value-based solutions, employers and brokers can finally break free from the old playbook — and build something better. McGriff is a Marsh & McLennan Agency LLC Company. Our solutions include commercial property and casualty, corporate bonding and surety, cyber, executive risk, management and professional liability, captives and alternative risk transfer programs, employee benefits, small business and personal lines insurance.

The Hill

17 hours ago

• The Hill

Thanks to imported drugs, America has lost control of its medicine cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicines. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe. At the root of it is a hard truth: We no longer have control of the medicines we depend on every day. In 2002, America manufactured 83.7 percent of the pharmaceuticals it consumed. By 2024, that number had dropped to just 37.1 percent. Meanwhile, the U.S. pharmaceutical trade deficit has soared, reaching a record $118.3 billion in 2024. We didn't just outsource manufacturing — we outsourced the sovereignty and safety of our health care system. This means that nearly two-thirds of America's pharmaceutical supplies are now imported. Most critical medications, such as generic drugs, now come from China and India. China controls 80 to 90 percent of the global supply of active pharmaceutical ingredients — the chemical building blocks of modern medicine. Even drugs labeled 'Made in the USA' often chemically originate in China. And India, which produces about half of America's finished generic drugs, relies on China for up to 80 percent of its active pharmaceutical not a supply chain — it's a ticking time something goes wrong, American patients suffer. In 2023, the Food and Drug Administration shut down a single Indian plant responsible for 50 percent of the U.S. supply of cisplatin, a critical chemotherapy drug, after uncovering a 'cascade of failure' in safety practices and shredded documents soaked in acid. With no domestic backup, patients nationwide had their treatments delayed. That wasn't a fluke. 40 percent of U.S. generic drugs have only one FDA-approved manufacturer. Because of that single chokepoint, when one factory fails, the whole system can crack. We are now seeing widespread drug shortages across the medical system. Hospital pharmacists report an average of 301 critical drug shortages at any given time. And 85 percent say these shortages are moderately or critically affecting care. Doctors often lack crucial medicines such as antibiotics, sedatives and cancer drugs. These aren't obscure drugs. They're foundational medicines. But America no longer makes them. Even when imported drugs do arrive, they're not always safe. A 2025 study found that Indian generics are 54 percent more likely to cause serious side effects than their U.S.-made counterparts. Indian factory violations have also been tied to at least eight U.S. patient deaths. China's record is equally disturbing. In 2008, dozens of Americans died after receiving contaminated heparin from Chinese suppliers. This isn't what the American people want. In a national survey, 85 percent of hospital pharmacists said they would pay more for safer generics. But under today's rules, price overshadows quality. Hospitals have little oversight of drug quality — and foreign producers face few consequences for cutting corners. Even the federal government is flying blind. A 2023 Department of Defense review found that 22 percent of essential military-use drugs had unknown ingredient sourcing. That's a national security April, the Trump administration took a necessary step by launching an investigation into generic pharmaceutical imports that correctly frames the issue as a national security threat. But that recognition alone isn't enough. To address this crisis, Washington should impose targeted tariffs on generic drugs from adversarial nations. It must also rebuild domestic pharmaceutical production through tax credits and long-term contracts. America urgently needs full transparency in drug labeling to disclose where drugs and their ingredients are made. The FDA must step up — with stronger enforcement abroad and a ban on imports from repeat safety violators. And to secure critical ingredients during market disruptions, Washington must pursue a long-term vision that includes a 'strategic pharmaceutical reserve.' This isn't just protectionism. It's a restoration of America's medical security. No nation can call itself sovereign if it can't produce its own medicines, and no patient is safe if their health care depends on quality control in a factory 8,000 miles decades, we were told that offshoring production would make things cheaper, smoother and more efficient. But America can no longer depend on unstable foreign suppliers. It's time to restore our pharmaceutical independence and take back control of our medicine cabinet. Andrew Rechenberg is an economist at the Coalition for a Prosperous America.

Forbes

2 days ago

• Forbes

The Triple Threat Draining Workforce Productivity And Mental Health

Productivity and mental health are taking a hit for three reasons. Numbers never lie: it's why CEOs obsess over revenue targets, operational metrics, quarterly growth, and more. Yet beneath the spreadsheets and data dashboards lies an invisible crisis quietly eroding organizational strength and productivity: the deteriorating mental health and emotional resilience of today's workforce. A comprehensive 2025 State of the Workforce Report by meQuilibrium, surveying 5,477 employees across various industries, identified a troublesome "triple threat" that undermines employee performance and well-being: uncertainty, pessimism, and psychological disconnection. These aren't mere HR concerns; they're operational risks with quantifiable financial impacts. The data paints a clear picture: These challenges are silently sabotaging productivity, further inflating turnover costs, and increasingly impacting employee well-being. The Real Cost Of The Triple Threat Uncertainty alone led to a 68% increase in productivity impairment. Employees facing high uncertainty stress experience twice the risk of generalized anxiety disorders and nearly double the rate of burnout, costing American companies between $4,000 and $21,000 per employee annually, according to a study in the American Journal of Preventive Medicine. Pessimism compounds this impact significantly. Workers with negative job outlooks report a 64% decrease in productivity, alongside a staggering 128% higher risk of depression and 108% higher risk of anxiety compared to optimistic colleagues. The psychological disconnect further exacerbates productivity losses. Even employees displaying no signs of disconnect report an average productivity impairment of 29%, while severely disconnected employees experience impairment rates of up to 66%. This triple threat isn't fleeting; it's systemic and escalating, making employee mental health and emotional resilience one of your organization's significant, yet often overlooked, financial liabilities. Foundational Strategies To Improve Productivity And Mental Health A company thrives when its people thrive. Amid volatility and continuous disruptions, the greatest threat to any organization is a workforce characterized by stress, negativity, disengagement, and poor health. However, this crisis presents opportunities to cultivate resilience and strength. While each company is unique, these foundational actions can universally elevate employee well-being and productivity: Fitness offers more than aesthetics. It's a strategic investment. CEOs like Bob Iger strongly advocate for fitness because it improves their mood, focus, emotional regulation, executive presence, and resilience. To build a health-driven culture, leaders must actively model wellness practices. Sleep is equally critical. Improved sleep and recovery improve individuals' decision-making and emotional regulation and reduce team volatility. Prioritizing a health-first culture also serves as a strong talent attractor and retention tool. Ambiguity breeds stress, especially with technological disruptions like AI, which create concerns about job stability. Clear and consistent communication significantly mitigates uncertainty. Leaders must frequently reiterate their vision in a way that integrates each person seamlessly. Also key is establishing priorities and performance expectations along with transparency in explaining the rationale behind decisions. Vulnerability and candor strengthen trust, which further reduces speculation and disengagement among employees and investors alike. Soft skills matter significantly, even in the data-driven corporate world. As highlighted in the report, empathetic managers reduce uncertainty stress by 37% and disconnect by nearly 50%. CEOs and senior leaders can actively cultivate empathy through the following: Better Mental Well-Being Equals Improved Productivity Addressing the triple threat isn't merely beneficial—it's critical. The modern workforce faces numerous challenges that threaten employees' mental health and productivity. With ongoing volatility and persistent uncertainty, investing in mental health and resilience becomes not just advantageous but essential. As technology democratizes and ceases to offer unique competitive advantages, the companies that will lead tomorrow are those who invest significantly in their people's well-being today.